Results of a randomized, double‐blind, parallel‐group, placebo‐ and active‐controlled, multicenter study of mirabegron, a β3‐adrenoceptor agonist, in patients with overactive bladder in Asia

Publisher: John Wiley & Sons Inc

E-ISSN: 1520-6777|34|7|685-692

ISSN: 0733-2467

Source: NEUROUROLOGY AND URODYNAMICS, Vol.34, Iss.7, 2015-09, pp. : 685-692

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content